https://vergegenomics.com
301
→
https://www.vergegenomics.com/
200
Summary
This business specializes in AI-powered drug discovery, focusing on developing innovative treatments for significant medical challenges. Utilizing a proprietary multi-omics database derived from human tissue, the company employs machine learning to identify disease causes and create drug candidates. Their first drug targets amyotrophic lateral sclerosis (ALS) and they are also working on treatments for Parkinson's Disease and Frontotemporal Dementia.
